Healthcare provider profile · identity verified

Nathan Shane Balusik

Family Practice · WATERVILLE, OH · NPI 1407174576

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	468	127
Amlodipine Besylate	Amlodipine Besylate	283	74
Levothyroxine Sodium	Levothyroxine Sodium	245	60
Lisinopril	Lisinopril	235	70
Omeprazole	Omeprazole	208	56
Pantoprazole Sodium	Pantoprazole Sodium	206	55
Furosemide	Furosemide	146	50
Alprazolam	Alprazolam	143	32
Prednisone	Prednisone	140	101
Tamsulosin Hcl	Tamsulosin Hcl	140	42
Rosuvastatin Calcium	Rosuvastatin Calcium	135	41
Losartan Potassium	Losartan Potassium	134	41
Carvedilol	Carvedilol	132	37
Mirtazapine	Mirtazapine	126	16
Gabapentin	Gabapentin	125	35
Cephalexin	Cephalexin	120	79
Trazodone Hcl	Trazodone Hcl	120	33
Metoprolol Succinate	Metoprolol Succinate	116	37
Eliquis	Apixaban	112	24
Lorazepam	Lorazepam	110	33
Tramadol Hcl	Tramadol Hcl	109	36
Potassium Chloride	Potassium Chloride	107	31
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	106	25
Celecoxib	Celecoxib	105	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	100	36
Escitalopram Oxalate	Escitalopram Oxalate	99	25
Metoprolol Tartrate	Metoprolol Tartrate	98	33
Metformin Hcl	Metformin Hcl	90	28
Sertraline Hcl	Sertraline Hcl	89	24
Fluoxetine Hcl	Fluoxetine Hcl	84	19
Bupropion Xl	Bupropion Hcl	83	19
Azithromycin	Azithromycin	80	74
Metformin Hcl Er	Metformin Hcl	78	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	75	23
Meloxicam	Meloxicam	75	23
Pravastatin Sodium	Pravastatin Sodium	75	19
Quetiapine Fumarate	Quetiapine Fumarate	74	15
Buspirone Hcl	Buspirone Hcl	70	11
Glipizide Er	Glipizide	69	17
Ozempic	Semaglutide	69	14
Finasteride	Finasteride	68	12
Allopurinol	Allopurinol	64	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	63	19
Clopidogrel	Clopidogrel Bisulfate	60	19
Xarelto	Rivaroxaban	60	suppressed
Donepezil Hcl	Donepezil Hcl	58	13
Duloxetine Hcl	Duloxetine Hcl	58	20
Januvia	Sitagliptin Phosphate	58	12
Ropinirole Hcl	Ropinirole Hcl	57	12
Simvastatin	Simvastatin	57	17
Pioglitazone Hcl	Pioglitazone Hcl	56	suppressed
Clonazepam	Clonazepam	55	11
Spironolactone	Spironolactone	54	17
Hydrochlorothiazide	Hydrochlorothiazide	53	14
Doxycycline Hyclate	Doxycycline Hyclate	51	44
Fluticasone Propionate	Fluticasone Propionate	51	21
Albuterol Sulfate Hfa	Albuterol Sulfate	50	18
Propranolol Hcl Er	Propranolol Hcl	50	suppressed
Memantine Hcl	Memantine Hcl	49	suppressed
Baclofen	Baclofen	48	12
Citalopram Hbr	Citalopram Hydrobromide	48	15
Montelukast Sodium	Montelukast Sodium	46	13
Pregabalin	Pregabalin	46	suppressed
Bumetanide	Bumetanide	45	13
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	45	25
Famotidine	Famotidine	44	suppressed
Tizanidine Hcl	Tizanidine Hcl	43	23
Diclofenac Sodium	Diclofenac Sodium	41	18
Diazepam	Diazepam	40	21
Glimepiride	Glimepiride	39	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	35	15
Valacyclovir	Valacyclovir Hcl	35	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Ezetimibe	Ezetimibe	34	suppressed
Fluconazole	Fluconazole	34	19
Warfarin Sodium	Warfarin Sodium	34	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	33	suppressed
Levetiracetam	Levetiracetam	33	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	33	suppressed
Constulose	Lactulose	32	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	31	12
Jardiance	Empagliflozin	31	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Atenolol	Atenolol	29	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	12
Triamcinolone Acetonide	Triamcinolone Acetonide	29	19
Ipratropium Bromide	Ipratropium Bromide	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Risperidone	Risperidone	28	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	27	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	26	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	23	suppressed
Mupirocin	Mupirocin	23	19
Synthroid	Levothyroxine Sodium	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Ketoconazole	Ketoconazole	21	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	14
Ibuprofen	Ibuprofen	20	suppressed
Liothyronine Sodium	Liothyronine Sodium	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	19	12
Eszopiclone	Eszopiclone	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Temazepam	Temazepam	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Divalproex Sodium	Divalproex Sodium	18	suppressed
Verapamil Er	Verapamil Hcl	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Paliperidone Er	Paliperidone	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	16
Ramipril	Ramipril	17	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Lacosamide	Lacosamide	16	suppressed
Nystatin	Nystatin	16	11
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Phenobarbital	Phenobarbital	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Ondansetron Odt	Ondansetron	15	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Aripiprazole	Aripiprazole	14	suppressed
Carbamazepine	Carbamazepine	14	suppressed
Carbamazepine Er	Carbamazepine	14	suppressed
Glipizide	Glipizide	14	suppressed
Minocycline Hcl	Minocycline Hcl	14	suppressed
Prolia	Denosumab	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Cefdinir	Cefdinir	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	11
Potassium Citrate Er	Potassium Citrate	11	suppressed
Sucralfate	Sucralfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error